These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36836483)

  • 1. Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy.
    Lan A; Li H; Chen J; Shen M; Jin Y; Dai Y; Jiang L; Dai X; Peng Y; Liu S
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast Cancer.
    Lan A; Chen J; Li C; Jin Y; Wu Y; Dai Y; Jiang L; Li H; Peng Y; Liu S
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
    Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
    World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
    Hwang HW; Jung H; Hyeon J; Park YH; Ahn JS; Im YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Choi M; Cho SY; Cho EY
    Breast Cancer Res Treat; 2019 Jan; 173(2):255-266. PubMed ID: 30324273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the impact of residual tumors at different sites post-neoadjuvant chemotherapy on prognosis in breast cancer patients and development of a disease-free survival prediction model.
    Yang H; Ruan Y; Sun Y; Wang P; Qiao J; Wang C; Liu Z
    Ther Adv Med Oncol; 2024; 16():17588359241249578. PubMed ID: 38736552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy.
    Gao S; Tang W; Zuo B; Mulvihill L; Yu J; Yu Y
    Front Oncol; 2022; 12():1065606. PubMed ID: 36727046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.
    Yan S; Wang W; Zhu B; Pan X; Wu X; Tao W
    Cancer Manag Res; 2020; 12():8313-8323. PubMed ID: 32982426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.
    Qu F; Luo Y; Peng Y; Yu H; Sun L; Liu S; Zeng X
    Front Immunol; 2023; 14():1335546. PubMed ID: 38274836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
    Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.
    Cabrera-Galeana P; Muñoz-Montaño W; Lara-Medina F; Alvarado-Miranda A; Pérez-Sánchez V; Villarreal-Garza C; Quintero RM; Porras-Reyes F; Bargallo-Rocha E; Del Carmen I; Mohar A; Arrieta O
    Oncologist; 2018 Jun; 23(6):670-678. PubMed ID: 29490940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
    Yang X; Rao J; Yang W; Shui R
    Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 14. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
    Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
    Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
    Resende U; Cabello C; Ramalho SOB; Zeferino LC
    BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
    Kim SY; Cho N; Choi Y; Lee SH; Ha SM; Kim ES; Chang JM; Moon WK
    Radiology; 2021 May; 299(2):290-300. PubMed ID: 33754824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Combining Both Clinicopathological and Imaging Indicators.
    Wang H; Lu Y; Li Y; Li S; Zhang X; Geng C
    Curr Probl Cancer; 2022 Dec; 46(6):100914. PubMed ID: 36351312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram.
    Cui H; Zhao D; Han P; Zhang X; Fan W; Zuo X; Wang P; Hu N; Kong H; Peng F; Wang Y; Tian J; Zhang L
    Front Oncol; 2021; 11():718531. PubMed ID: 34888231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
    Vila J; Mittendorf EA; Farante G; Bassett RL; Veronesi P; Galimberti V; Peradze N; Stauder MC; Chavez-MacGregor M; Litton JF; Huo L; Kuerer HM; Hunt KK; Caudle AS
    Ann Surg Oncol; 2016 Oct; 23(11):3501-3509. PubMed ID: 27216742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
    Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
    World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.